Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,000
Closed -$363K 1183
2020
Q2
$363K Buy
+8,000
New +$409K 0.01% 786
2019
Q1
Sell
-6,920
Closed -$259K 1174
2018
Q4
$259K Buy
+6,920
New +$270K 0.01% 899

Other funds holding ATEX

Stephens Inc's ATEX Position: Q3 2020 in Review

Stephens Inc sold out of Anterix (ATEX) in Q3 2020, closing a stake of 8,000 shares — an estimated $363K sold.

Stephens Inc first reported a position in ATEX in Q4 2018 and held it in 2 quarters. The position peaked at $363K in Q2 2020. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.

  • Stephens Inc reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
  • Stephens Inc sold 8,000 Anterix shares in Q3 2020, an estimated $363K.
  • Stephens Inc first reported a position in Anterix in Q4 2018 and held it in 2 quarters.
  • Stephens Inc's Anterix position peaked at $363K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.

Based on Stephens Inc's 13F filing for Q3 2020, filed 13 Nov 2020.